In response to MDK knockdown, siRNA (small interfering RNA), or MDK inhibitor, not only did MDK-induced endothelial cell migration and angiogenesis decrease, but the progression and metastasis of NSCLC cells in vitro and in vivo also discontinued. Here, MDK is linked to non-small cell lung carcinoma.